Microbiota, Oxidative Stress and Epithelial Diseases

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".

Deadline for manuscript submissions: 15 November 2024 | Viewed by 531

Special Issue Editors


E-Mail Website
Guest Editor
Department of Clinical and Biological Sciences, University of Turin, 10125 Turin, Italy
Interests: lipid peroxidation; oxidative stress; cancer; chemoresistance; resistance to targeted therappies; melanoma; nanomedicine
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Health Sciences, Università del Piemonte Orientale (UPO), 28100 Novara, Italy
Interests: non-melanoma skin cancer; head and neck squamous cell carcinoma; probiotics; prebiotics and postbiotics; S. aureus; P. gingivalis; F. nucleatum; P. aeruginosa; S. mutans; S. mitis

Special Issue Information

Dear Colleagues,

We are pleased to serve as Guest Editors for the new Special Issue "Microbiota, Oxidative Stress and Epithelial Diseases."

Mounting evidence demonstrates the important role of oxidative stress in the pathogenesis of several medical conditions, including epithelial diseases. Elevated reactive oxygen species (ROS) can contribute, with different mechanisms, to their transformation and tumoral progression, including non-melanoma skin cancer, melanoma, head and neck squamous cell carcinoma, genital, colon, or breast malignancies. Moreover, several chronic benign inflammatory conditions involving epithelial tissues, such as atopic dermatitis, psoriasis, inflammatory bowel disease, or asthma, are associated with oxidative stress.

In the last few decades, microbiota has been identified as a major player in several human pathological conditions. Indeed, microbiota unbalance, named dysbiosis, is associated with the onset, progression, relapse, and resistance to therapies in several epithelial cancers. Moreover, alteration of the microbiota niches is closely linked to the pathogenesis of several inflammatory epithelial diseases.

It is well-known that dysbiosis can be associated with oxidative stress and/or inflammation. However, although their interplay has been somewhat suggested, the connection between microbiota, oxidative stress, and epithelial diseases is still a largely unexplored field.

This Special Issue welcomes original research and literature reviews concerning the connection between microbiota and oxidative stress in epithelial diseases.

Dr. Stefania Pizzimenti
Dr. Barbara Azzimonti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • microbiota
  • oxidative stress
  • epithelial diseases
  • non-melanoma skin cancer
  • melanoma
  • head and neck squamous cell carcinoma
  • breast, genital, colon or other epithelial cancers
  • atopic dermatitis or other skin inflammatory conditions
  • inflammatory bowel disease
  • asthma

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 5630 KiB  
Article
A Novel Foodstuff Mixture Improves the Gut–Liver Axis in MASLD Mice and the Gut Microbiota in Overweight/Obese Patients
by Rebeca Rosas-Campos, Ana Soledad Sandoval-Rodríguez, Jonathan Samael Rodríguez-Sanabria, Ángel Omar Vazquéz-Esqueda, Carlos Roberto Alfaro-Martinez, Rebeca Escutia-Gutiérrez, Natali Vega-Magaña, Marcela Peña-Rodríguez, José Sergio Zepeda-Nuño, Mauricio Andrade-Marcial, Yolanda Campos-Uscanga, Luis Felipe Jave-Suárez, Arturo Santos, Eira Cerda-Reyes, Mónica Almeida-López, Erika Martínez-López, Luis Alonso Herrera and Juan Armendariz-Borunda
Antioxidants 2024, 13(6), 664; https://doi.org/10.3390/antiox13060664 - 29 May 2024
Viewed by 172
Abstract
Microbial community control is crucial for maintaining homeostasis of the gut–liver axis in metabolic dysfunction-associated steatotic liver disease (MASLD). Here, we show that supplementation with a mixture of Mexican foodstuffs (MexMix)—Opuntia ficus indica (nopal), Theobroma cacao (cocoa) and Acheta domesticus (crickets)—enriches several [...] Read more.
Microbial community control is crucial for maintaining homeostasis of the gut–liver axis in metabolic dysfunction-associated steatotic liver disease (MASLD). Here, we show that supplementation with a mixture of Mexican foodstuffs (MexMix)—Opuntia ficus indica (nopal), Theobroma cacao (cocoa) and Acheta domesticus (crickets)—enriches several beneficial taxa in MASLD mice and overweight/obese humans. Thus, MexMix induces an important prebiotic effect. In mice, a restoration of intestinal health was observed due to the increased short-chain fatty acids (SCFAs) and intestinal crypt depth, Ocln and Cldn1 expression, and decreased Il6 and Tnfa expression. MexMix significantly reduced steatosis in the mice’s liver and modified the expression of 1668 genes. By PCR, we corroborated a Tnfa and Pparg decrease, and a Cat and Sod increase. In addition, MexMix increased the hepatic NRF2 nuclear translocation and miRNA-34a, miRNA-103, and miRNA-33 decline. In overweight/obese humans, MexMix improved the body image satisfaction and reduced the fat intake. These findings indicate that this new food formulation has potential as a therapeutic approach to treat conditions associated with excessive consumption of fats and sugars. Full article
(This article belongs to the Special Issue Microbiota, Oxidative Stress and Epithelial Diseases)
Show Figures

Figure 1

Back to TopTop